Ten-year follow-up after intense chemoimmunotherapy with Rituximab-HyperCVAD alternating with Rituximab-high dose methotrexate/cytarabine (R-MA) and without stem cell transplantation in patients with untreated aggressive mantle cell lymphoma

Jorge E. Romaguera, Luis E. Fayad, Lei Feng, Kimberly Hartig, Pamela Weaver, Maria Alma Rodriguez, Fredrick B. Hagemeister, Barbara Pro, Peter McLaughlin, Anas Younes, Felipe Samaniego, Andre Goy, Fernando Cabanillas, Hagop Kantarjian, Larry Kwak, Michael Wang

Research output: Contribution to journalArticlepeer-review

211 Scopus citations

Fingerprint

Dive into the research topics of 'Ten-year follow-up after intense chemoimmunotherapy with Rituximab-HyperCVAD alternating with Rituximab-high dose methotrexate/cytarabine (R-MA) and without stem cell transplantation in patients with untreated aggressive mantle cell lymphoma'. Together they form a unique fingerprint.

Medicine & Life Sciences